Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Sections by Topic
    • Archives
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Trainee of the Year
    • Author Resources
    • Reprint Information
  • Editorial Team
  • Subscriptions
  • More
    • Advertising
    • Reprint Information
    • Impact Factor
    • About CJASN
    • Feedback
    • CJASN Relaunch
  • Other
    • JASN
    • Kidney News Online
    • In the Loop
    • American Society of Nephrology

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney News Online
    • In the Loop
    • American Society of Nephrology
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Sections by Topic
    • Archives
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Trainee of the Year
    • Author Resources
    • Reprint Information
  • Editorial Team
  • Subscriptions
  • More
    • Advertising
    • Reprint Information
    • Impact Factor
    • About CJASN
    • Feedback
    • CJASN Relaunch
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Original Article
You have accessRestricted Access

Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease

Joshua D. Bundy, Lydia A. Bazzano, Dawei Xie, Janet Cohan, Jacqueline Dolata, Jeffrey C. Fink, Chi-yuan Hsu, Kenneth Jamerson, James Lash, Gail Makos, Susan Steigerwalt, Xue Wang, Katherine T. Mills, Jing Chen, Jiang He and the CRIC Study Investigators
CJASN June 2018, CJN.11121017; DOI: https://doi.org/10.2215/CJN.11121017
Joshua D. Bundy
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua D. Bundy
Lydia A. Bazzano
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dawei Xie
Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet Cohan
Department of Medicine, University of Illinois, Chicago, Illinois;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacqueline Dolata
Division of Nephrology, Case Western Reserve University, Cleveland, Ohio;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey C. Fink
Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chi-yuan Hsu
Division of Nephrology, University of California San Francisco, San Francisco, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Jamerson
Division of Cardiovascular Medicine, University of Michigan Health System, Ann Arbor, Michigan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Lash
Department of Medicine, University of Illinois, Chicago, Illinois;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gail Makos
Division of Nephrology, St. John Hospital and Medical Center, Detroit, Michigan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Steigerwalt
Division of Nephrology, University of Michigan School of Medicine, Ann Arbor, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xue Wang
Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine T. Mills
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Chen
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiang He
Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Visual Overview

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Abstract

Background and objectives Previous studies suggest that tobacco, alcohol, and illicit drug use is associated with CKD. We examined the associations of substance use with CKD progression and all-cause mortality among patients with CKD.

Design, setting, participants, & measurements The Chronic Renal Insufficiency Cohort Study is a prospective, longitudinal cohort study among 3939 participants with CKD in the United States. Self-reported tobacco smoking, alcohol drinking, marijuana use, and hard illicit drug (cocaine, heroin, or methamphetamine) use were obtained at baseline and annual follow-up visits. CKD progression was defined as incident ESKD or halving of eGFR. Substance use was modeled as the cumulative average exposure to capture both recent and long-term use in multivariable time-dependent Cox regression.

Results Over a median 5.5-year follow-up, 1287 participants developed CKD progression, and 1001 died. Baseline proportions of tobacco smoking, alcohol drinking, marijuana use, and hard illicit drug use were 13%, 20%, 33%, and 12%, respectively. Compared with nonsmoking throughout follow-up, multivariable-adjusted hazard ratios for persistent tobacco smoking were 1.02 (95% confidence interval, 0.86 to 1.21) for CKD progression and 1.86 (95% confidence interval, 1.54 to 2.24) for all-cause mortality. Compared with nondrinking throughout follow-up, multivariable-adjusted hazard ratios for persistent alcohol drinking were 1.06 (95% confidence interval, 0.88 to 1.29) for CKD progression and 0.73 (95% confidence interval, 0.58 to 0.91) for all-cause mortality. Compared with nonuse throughout follow-up, multivariable-adjusted hazard ratios for persistent marijuana use were 0.94 (95% confidence interval, 0.82 to 1.07) for CKD progression and 1.11 (95% confidence interval, 0.96 to 1.30) for all-cause mortality. Compared with nonuse throughout follow-up, multivariable-adjusted hazard ratios for persistent hard illicit drug use were 1.25 (95% confidence interval, 1.00 to 1.55) for CKD progression and 1.41 (95% confidence interval, 1.10 to 1.81) for all-cause mortality.

Conclusions Hard illicit drug use is associated with higher risk of CKD progression and all-cause mortality, tobacco smoking is associated with higher risk of all-cause mortality, and alcohol drinking is associated with lower risk of all-cause mortality among patients with CKD.

  • Alcohol Drinking
  • chronic kidney disease
  • Cocaine
  • Confidence Intervals
  • Disease Progression
  • Epidemiology and outcomes
  • Follow-up Studies
  • glomerular filtration rate
  • Heroin
  • Humans
  • Kidney Failure, Chronic
  • Marijuana Use
  • Methamphetamine
  • mortality
  • progression of chronic renal failure
  • Prospective Studies
  • Renal Insufficiency, Chronic
  • risk factors
  • Self Report
  • Street Drugs
  • Tobacco Smoking
  • Received October 4, 2017.
  • Accepted April 5, 2018.
  • Copyright © 2018 by the American Society of Nephrology
View Full Text

If you do not have an account on CJASN or JASN, you will need to create one.  See the instructions below for details on how to create an account. 

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.

Purchase access

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$27.00

When you create an account, you will be asked for your name, email address and other information.  Just like commercial web sites, we do need details from you in order to complete your purchase of an article.  Select the "Create an Account" link to create your account. 

You will then be asked to register a user name, email address and you will need to create a password that is at least eight characters in length. As you move through the registration page, you will have to verify you are a person by completing a Captcha request.   Lastly, your first and last name will be required. 

Once your information is successfully saved, the system will redisplay the home page of the journal.  From there, navigate back to the article to purchase.  Select the article and at the bottom of the page, use the credentials you just created to login. The article will be added to your shopping cart.  You can continue to navigate across JASN and CJASN adding to your cart from both journals. When you are ready to complete your purchse, select the Shopping Cart from the upper right hand corner of the page and follow the onscreen instructions. 

PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 14 (2)
Clinical Journal of the American Society of Nephrology
Vol. 14, Issue 2
February 07, 2019
  • Table of Contents
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
Citation Tools
Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease
Joshua D. Bundy, Lydia A. Bazzano, Dawei Xie, Janet Cohan, Jacqueline Dolata, Jeffrey C. Fink, Chi-yuan Hsu, Kenneth Jamerson, James Lash, Gail Makos, Susan Steigerwalt, Xue Wang, Katherine T. Mills, Jing Chen, Jiang He, the CRIC Study Investigators
CJASN Jun 2018, CJN.11121017; DOI: 10.2215/CJN.11121017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease
Joshua D. Bundy, Lydia A. Bazzano, Dawei Xie, Janet Cohan, Jacqueline Dolata, Jeffrey C. Fink, Chi-yuan Hsu, Kenneth Jamerson, James Lash, Gail Makos, Susan Steigerwalt, Xue Wang, Katherine T. Mills, Jing Chen, Jiang He, the CRIC Study Investigators
CJASN Jun 2018, CJN.11121017; DOI: 10.2215/CJN.11121017
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

More in this TOC Section

  • Central Venous Stenosis, Access Outcome and Survival in Patients undergoing Maintenance Hemodialysis
  • Urinary Potassium Excretion and Progression of Chronic Kidney Disease
  • Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria
Show more Original Article

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • Scopus
  • PubMed
  • Google Scholar

Keywords

  • Alcohol Drinking
  • chronic kidney disease
  • Cocaine
  • Confidence Intervals
  • Disease Progression
  • Epidemiology and outcomes
  • Follow-Up Studies
  • glomerular filtration rate
  • Heroin
  • Humans
  • Kidney Failure, Chronic
  • Marijuana Use
  • Methamphetamine
  • mortality
  • progression of chronic renal failure
  • Prospective Studies
  • Renal Insufficiency, Chronic
  • risk factors
  • Self Report
  • Street Drugs
  • Tobacco Smoking

About

  • ASN
  • CJASN
  • ASN Journals
  • ASN Podcasts
  • CJASN Relaunch

Author Information

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • Reuse/Reprint Policy

More information

  • Advertise
  • Subscribe
  • Email Alerts
  • Sections by Topic

© 2019 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire